2025-12-19 - Analysis Report
Here's a comprehensive analysis of Northrop Grumman (NOC) based on the provided data:

**0) Overview:**

*   **Simple Numbers First:** The data is presented below, followed by a breakdown and analysis.

**1) Return Rate Comparison & Alpha/Beta Analysis**

*   **Company Overview:** Northrop Grumman Corp is a leading global aerospace and defense technology company.
*   **Return Rate:**
    *   NOC Cumulative Return: 45.18%
    *   VOO (S&P 500) Cumulative Return: 99.09%
    *   Divergence: -52.2 (Relative Divergence: 6.2)

*   **Analysis:**
    *   NOC has significantly underperformed the S&P 500 (VOO) over the specified period. The divergence of -52.2 indicates a substantial difference in cumulative returns. The relative divergence of 6.2 suggests the current divergence is near the lower end of its historical range. This means that the stock has more upside potential than downside potential when compared to the minimum-maximum divergence range of the past data, but this is only a statistical measure.

*   **Alpha, Beta and CAGR Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | 46.0%   | 65.6% | 17.0%   | 0.0   | 43.9   |
| 2016-2018  | -2.0%   | 74.3% | -17.0%  | 0.0   | 35.1   |
| 2017-2019  | 17.0%   | 79.2% | -5.0%   | 0.9   | 49.2   |
| 2018-2020  | -28.0%  | 79.9% | -52.0%  | 0.8   | 43.6   |
| 2019-2021  | 43.0%   | 79.9% | -4.0%   | 0.8   | 55.4   |
| 2020-2022  | 18.0%   | 79.9% | 19.0%   | 0.3   | 78.1   |
| 2021-2023  | 24.0%   | 82.7% | 23.0%   | 0.2   | 67.0   |
| 2022-2024  | -15.0%  | 82.7% | -36.0%  | 0.2   | 67.2   |
| 2023-2025  | -5.0%   | 82.1% | -69.0%  | 0.1   | 80.1   |

*   **Analysis:**
    *   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly year to year, showing periods of strong growth and contraction.
    *   **MDD (Maximum Drawdown):** Consistently high, indicating substantial risk or volatility. The MDD is very close to 80% for almost all periods.
    *   **Alpha:** Largely negative in recent periods, suggesting NOC is underperforming relative to its risk (Beta) and market conditions.
    *   **Beta:** Generally low (close to 0), implying NOC's price is not strongly correlated with the overall market (S&P 500). The recent Beta is very close to 0, meaning that the price is less sensitive to market movements.
    *   **Cap(B) (Market Capitalization in Billions):** Has generally increased over time, suggesting overall growth in the company's value despite volatility.

**2) Recent Stock Price Fluctuations:**

*   Close: 559.52
*   Last Market: {'price': 559.52, 'previousClose': 564.19, 'change': -0.83}
*   5-day SMA: 567.60
*   20-day SMA: 560.71
*   60-day SMA: 581.61

*   **Analysis:** The price is below all moving averages, particularly the 60-day SMA, suggesting a downward trend. The 5-day SMA being above the 20-day SMA suggests a possible short-term bounce, but the overall trend is negative.

**3) RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return:**

*   MRI: 0.7 (Medium Investment Recommended)
*   RSI: 42.45 (Neutral)
*   PPO: 0.37
*   Hybrid Signal: cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   Recent (20 days) relative divergence change = 5.2 (+): 단기상승 (Short-term rise)
*   Expected Return (%): -120.2

*   **Analysis:**
    *   The MRI suggests a medium level of investment risk.
    *   RSI is neutral, not indicating overbought or oversold conditions.
    *   A positive PPO suggests a short-term bullish trend.
    *   The hybrid signal recommends a buy based on a very safe rating with dividend yield and a monthly investment strategy.
    *   The positive change in relative divergence over the last 20 days suggests a short-term upward movement.
    *   The very negative Expected Return suggests significant underperformance relative to the market in the long term. This is a strong warning sign.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **Positive:**
    *   Northrop Grumman Announces Fourth Quarter and Full-Year 2025 Earnings Release Date and Webcast Details.
    *   Northrop Grumman (NOC): Reassessing Valuation After Recent Pullback in a Strong Year for the Stock.
    *   YieldBoost NOC From 1.6% To 5% Using Options.

*   **Negative/Neutral:**
    *   Texas Permanent School Fund Corp Sells Shares of Northrop Grumman Corporation.
    *   Northrop Grumman (NOC): Assessing Value After Recent 5% Pullback in Share Price.
    *   3 Reasons to Sell NOC and 1 Stock to Buy Instead.

*   **Analysis:** The news is mixed. An upcoming earnings release and reassessment of valuation are potentially positive. However, a share sale and articles suggesting reasons to sell indicate concerns about the stock's performance.

**4-2) Analyst Opinions:**

*   Consensus: Buy (2.04)
*   Target Price (avg/high/low): 662.68 / 770.00 / 533.00

*   **Analysis:** Analysts generally have a positive outlook on the stock, with a "Buy" consensus and an average target price significantly higher than the current price. This represents substantial upside potential according to analyst estimates. However, it is important to note the low end of the target range is below the current price.

**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-10-21 | 7.69  | 10.42 B$    |
| 2025-07-22 | 8.17  | 10.35 B$    |
| 2025-04-22 | 3.33  | 9.47 B$     |
| 2024-10-24 | 7.02  | 10.00 B$    |
| 2025-10-21 | 7.02  | 10.00 B$    |

*   **Analysis:**
    *   Revenue is generally consistent around $10 Billion per quarter.
    *   EPS (Earnings Per Share) has fluctuated, with a noticeable dip in Q2 2025 (April).
    *   Recent EPS has recovered.

**6) Financial Information:**

*   **Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $10.42B    | 21.37%        |
| 2025-06-30   | $10.35B    | 21.35%        |
| 2025-03-31   | $9.47B     | 16.69%        |
| 2024-12-31   | $10.69B    | 18.08%        |
| 2024-09-30   | $10.00B    | 21.07%        |

*   **Capital and Profitability:**

| Quarter      | Equity     | ROE     |
|--------------|------------|---------|
| 2025-09-30   | $15.99B    | 6.88%   |
| 2025-06-30   | $15.47B    | 7.59%   |
| 2025-03-31   | $14.98B    | 3.21%   |
| 2024-12-31   | $15.29B    | 8.27%   |
| 2024-09-30   | $14.75B    | 6.96%   |

*   **Analysis:**
    *   **Revenue:** Generally stable, with a slight dip in early 2025.
    *   **Profit Margin:** Consistently high, usually above 21%, indicating good operational efficiency.
    *   **Equity:** Steadily increasing, suggesting healthy financial growth.
    *   **ROE (Return on Equity):** Fluctuating, with a significant drop in Q1 2025.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** NOC has significantly underperformed the S&P 500 in terms of cumulative return.
*   **Volatility:** High MDD values indicate substantial risk and price swings.
*   **Recent Downtrend:** Current price is below key moving averages, suggesting a recent downtrend.
*   **Mixed Signals:** The hybrid signal suggests a buy, while the expected return is alarmingly negative. Analyst consensus is positive, but some news headlines are concerning.
*   **Financial Health:** The company appears financially sound with increasing equity and healthy profit margins, though ROE has fluctuated.
*   **Concerns:** The extremely negative expected return is a major red flag and warrants careful consideration. Alpha values confirm the underperformance compared to the market. While analysts are optimistic, the historical data and recent price action suggest caution.
* **Recommendation:** Given the contradictory signals (analyst optimism vs. data warnings), further investigation is needed before making an investment decision. The negative expected return should be a primary focus of further research. Pay close attention to the upcoming earnings release and any updates to analyst ratings. Look for potential catalysts that could reverse the underperformance trend. Considering the relatively low beta of NOC compared to the market, and recent market volatility, this can be considered a relatively safe investment within the defense industry, however a more prudent approach should be taken.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.